You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
共同藥業(300966.SZ):丹創投、張欣擬合計減持不超3%股份
格隆匯 09-27 19:34

格隆匯9月27日丨共同藥業(300966.SZ)公佈,公司近日收到控股股東、實際控制人的一致行動人丹江口市共同創新投資合夥企業(有限合夥)(以下簡稱“丹創投”)、張欣出具的《關於股份減持計劃的吿知函》,丹創投持有本公司股份5,501,200股,佔本公司總股本的4.77%;張欣持有本公司股份1,490,900股,佔公司總股本的1.22%;丹創投、張欣計劃以集中競價交易方式或大宗交易方式減持公司股份不超過3,458,367股(即減持比例不超過公司當前總股本的3%)。以集中競價方式減持的,計劃在本公吿披露之日起15個交易日後的3個月內進行,且任意連續90日內減持股份總數不超過公司股份總數的1%;以大宗交易方式減持的,計劃在本公吿披露之日起15個交易日後的3個月內進行,且任意連續90日內減持股份總數不超過公司股份總數的2%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account